• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Section Contents Menu


Officer/Employee List - Prevnar 13

Proper Name: Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)
Tradename: Prevnar 13
Manufacturer: Wyeth Pharmaceuticals Inc.
STN: 125324/0
Approval Date: February 24, 2010

Officer/Employee List

The following officers or employees of FDA participated in the decision to approve this application and consented to be identified on this list:

Michael Smith

Julienne Vaillancourt

Tina Khoie

John Cipollo

Rajesh Gupta

Marthe Bryant-Genevier

Milan Blake

Drusilla Burns

Catherine Miller

Eugenia Dragunsky

Jingyee Kou

Michael Schmitt

Mustafa Akkoyunlu

Solomon Yimam

Tina Roecklein

Martha O’Lone

Patricia Holobaugh

Steve Rubin

Amelia Dale Horne


Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002